science_technology_and_other_research_and_development · DOD-AMRAA
DoW Kidney Cancer, Idea Development Award
Defense Health Agency Contracting Activity - DHACA · HT942526KCRPIDA
Total Program Funding
$7.8M
Expected Awards
8
Deadline
September 28, 2026
GRANTQUICK SUMMARYPlain-English Overview
DoD's Kidney Cancer Research Program Idea Development Award funds 8 grants ($7.8M total, ~$975K each) for innovative kidney cancer research that could change the field. Any career stage, any research phase (basic to translational, no clinical trials). Must address kidney cancer specifically and align with KCRP research priorities. The program's main investigator-initiated research mechanism.
Who Should Apply
Researchers at any stage with innovative kidney cancer research ideas. Must have preliminary/published data and address KCRP Areas of Emphasis.
Who Should NOT Apply
Researchers without kidney cancer focus, anyone proposing clinical trials, or investigators without relevant preliminary data.
Key Requirements (Plain English)
- •Must focus on kidney cancer research
- •Must present an innovative idea with potential to change the field
- •8 awards totaling $7.8M
- •Must include relevant preliminary/published data
- •No clinical trials
- •Unrestricted eligibility
💡 GrantQuick Tip
8 awards for kidney cancer is generous given the field's size. DoD research programs value military relevance — kidney cancer has higher incidence in military/veteran populations due to environmental exposures. If you can connect your research to military-relevant risk factors (burn pit exposure, PFAS, Agent Orange), that strengthens your application. But the science must be strong regardless — don't force a military angle if it doesn't fit naturally.
Competitiveness: Moderate — 8 awards in a mid-size oncology field. Strong science with clear innovation wins.
What This Grant Funds
Summary: The fiscal year 2026 (FY26) Kidney Cancer Research Program (KCRP) Idea Development Award (IDA) supports the development of high-impact ideas that advance the understanding of kidney cancer and ultimately lead to improved patient outcomes. The research project should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach. Personnel on the proposed team should have a strong background in kidney cancer research.
Distinctive Features:
· Partnering Principal Investigator Option: Supports meaningful and productive partnerships between two investigators, termed the Initiating Principal Investigator (PI) and Partnering PI, collaborating on a single application. Only the Initiating PI will submit a pre-application, but all PIs will need to submit full applications. The Partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Total Program Funding
- $7.8M
- Expected Number of Awards
- 8
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
help@eBRAP.orgReady to apply?
View the full NOFO and submit your application on Grants.gov